Raphael Pharmaceutical Inc (RAPH): L2 is VERY thin to $1.01

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: maronti1 post# 5374

Monday, 02/09/2009 8:49:26 PM

Monday, February 09, 2009 8:49:26 PM

L2 is VERY thin to $1.01

Don't take my advice, I'm just a poor Pastor with a Zecco account

Keep Last Read

Replies (2) Next 10 Prev Next

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 10:03:25 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 10:22:31 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:01:19 PM
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA) • GlobeNewswire Inc. • 11/17/2025 05:03:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:02:09 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 08:06:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 11:00:57 AM

Go Ad-Free